[Pharmacological studies of adenosine 3',5'-monophosphate and related compounds. 1. Effects of adenosine 3',5'-monophosphate and N6-2'-O-dibutyryl 3',5'-adenosine monophosphate on the renal function].
D000227:Adenine Nucleotides / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002712:Chlorides / Q000652:urine; D003404:Creatinine / Q000652:urine; D000242:Cyclic AMP / Q000494:pharmacology; D004285:Dogs; D005260:Female; D005919:Glomerular Filtration Rate; D006493:Heparin / Q000494:pharmacology; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D007444:Inulin; D007668:Kidney / Q000098:blood supply / Q000187:drug effects* / Q000502:physiology; D008297:Male; D011188:Potassium / Q000652:urine; D012039:Regional Blood Flow / Q000187:drug effects; D012964:Sodium / Q000652:urine; D013997:Time Factors; D014554:Urination / Q000187:drug effects; D014667:Vasopressins / Q000494:pharmacology
D000227:Adenine Nucleotides; D002712:Chlorides; D014667:Vasopressins; D006493:Heparin; D007444:Inulin; D012964:Sodium; D003404:Creatinine; D000242:Cyclic AMP; D011188:Potassium